Javascript must be enabled to continue!
The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens
View through CrossRef
AbstractEnterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter (ESKAPE) species as causative agents are characterized by increased levels of resistance toward multiple classes of first‐line as well as last‐resort antibiotics and represent serious global health concerns, creating a critical need for the development of novel antibacterials with therapeutic potential against drug‐resistant ESKAPE species. Indole derivatives with structural and mechanistic diversity demonstrated broad‐spectrum antibacterial activity against various clinically important pathogens including drug‐resistant ESKAPE. Moreover, several indole‐based agents that are exemplified by creatmycin have already been used in clinics or under clinical trials for the treatment of bacterial infections, demonstrating that indole derivatives hold great promise for the development of novel antibacterials. This review is an endeavor to highlight the current scenario of indole hybrids, dimers, and trimers with therapeutic potential against drug‐resistant ESKAPE pathogens, covering articles published from 2020 to the present, to open new avenues for the exploration of novel antidrug‐resistant ESKAPE candidates.
Title: The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens
Description:
AbstractEnterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter (ESKAPE) species as causative agents are characterized by increased levels of resistance toward multiple classes of first‐line as well as last‐resort antibiotics and represent serious global health concerns, creating a critical need for the development of novel antibacterials with therapeutic potential against drug‐resistant ESKAPE species.
Indole derivatives with structural and mechanistic diversity demonstrated broad‐spectrum antibacterial activity against various clinically important pathogens including drug‐resistant ESKAPE.
Moreover, several indole‐based agents that are exemplified by creatmycin have already been used in clinics or under clinical trials for the treatment of bacterial infections, demonstrating that indole derivatives hold great promise for the development of novel antibacterials.
This review is an endeavor to highlight the current scenario of indole hybrids, dimers, and trimers with therapeutic potential against drug‐resistant ESKAPE pathogens, covering articles published from 2020 to the present, to open new avenues for the exploration of novel antidrug‐resistant ESKAPE candidates.
Related Results
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Abstract
Introduction: Pleural empyema is the collection of pus within the pleural cavity, typically arising as a complication of pneumonia, chest trauma, thoracic surgery, or bact...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
MO318: Utility of D-Dimer Levels in Predicting the Renal Outcome of Acute Kidney Injury in Moderate and Severe COVID-19: A Retrospective Study
MO318: Utility of D-Dimer Levels in Predicting the Renal Outcome of Acute Kidney Injury in Moderate and Severe COVID-19: A Retrospective Study
Abstract
BACKGROUND AND AIMS
Acute kidney injury (AKI) is a potential complication of COVID-19 and the hypercoagulation tendency...
Downregulation of Klebsiella pneumoniae RND efflux pump genes following indole signal produced by Escherichia coli
Downregulation of Klebsiella pneumoniae RND efflux pump genes following indole signal produced by Escherichia coli
Abstract
Background
More than a century has passed since it was discovered that many bacteria prod...
Downregulation of Klebsiella pneumoniae RND efflux pump following indole signal produced by Escherichia coli
Downregulation of Klebsiella pneumoniae RND efflux pump following indole signal produced by Escherichia coli
Abstract
Background
More than a century has passed since it was discovered that many bacteria produce indole, but research into the actual biological roles of this molecul...
Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q
Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q
Abstract
Serum amyloid P component (SAP) was polymerized using the cleavable cross-linker 3,3’-dithio-bis-(sulfo-succinimidylpropionate) to study its interaction ...
WHO Priority Pathogens, ESKAPE Bacteria, and AMR Surveillance in Household Wastewater, Gombe, Nigeria
WHO Priority Pathogens, ESKAPE Bacteria, and AMR Surveillance in Household Wastewater, Gombe, Nigeria
Abstract
Background: WHO bacterial priority pathogens and ESKAPE organisms in household wastewater pose critical community transmission risks, yet surveillance data from Sub-Sahara...

